IHH Healthcare's Q3 PATMI Comes In Flat
IHH Healthcare's Q3 PATMI Comes In Flat
The lower headline PATMI was primarily due to a high base last year, which recorded one-off gains of RM873.0 million from the sale of International Medical University. Excluding exceptional items, PATMI (ex EI) grew by 35%.
IHH Healthcare reported its third quarter financial performance recording revenue and EBITDA of RM5.6 billion and RM1.3 billion respectively. Across all key markets, IHH saw higher inpatient volumes as well as revenue intensity from taking on more complex cases. Excluding the effects of MFRS 129, revenue and EBITDA would have grown by 10% and 7% respectively.
ihh医疗保健集团报告了其第三季度的财务表现，营业收入和EBITDA分别为56亿林吉特和13亿林吉特。在所有主要市场上，ihh医疗保健集团看到了住院病人数量增加以及通过承担更复杂病例而带来的收入强度提高。排除MFRS 129的影响，营业收入和EBITDA将分别增长10%和7%。
PATMI however was flat against last year at RM534 million versus RM532 million in Q3FY23. Excluding exceptional items, PATMI (ex EI) was up 43% on core operational growth.
然而，去年同期的净利润归属于母公司股东为53400万林吉特，与2023年第三季度的53200万林吉特持平。排除异常项目，净利润归属于母公司股东（不含EI）因核心运营增长而增长了43%。
As for year to date, revenue and EBITDA reported double-digit growth on sustained growth in patient volumes and revenue intensity across all markets, at 13% and 12% respectively.
至今为止，营业收入和EBITDA报告的双位数增长在所有市场的持续病人数量增长和收入强度增长中，分别为13%和12%。
The lower headline PATMI was primarily due to a high base last year, which recorded one-off gains of RM873.0 million from the sale of International Medical University. Excluding exceptional items, PATMI (ex EI) grew by 35%.
较低的净利润归属于母公司股东主要是由于去年的高基数，当时因出售国际医科大学而录得87300万林吉特的一次性收益。排除异常项目，净利润归属于母公司股东（不含EI）增长了35%。
Balance sheet remained strong: net cash generated from operating activities at RM3.1
billion; net gearing at healthy 0.24x.
资产负债表仍然强劲：经营活动产生的净现金为31亿林吉特；健康的净负债率为0.24倍。
十亿；健康的净负债率为0.24倍。
